{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T07:00:44Z","timestamp":1794294044052,"version":"4.9.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jocn.2022.10.017","type":"journal-article","created":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T01:01:23Z","timestamp":1666400483000},"page":"117-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Correlation between neutrophil-to-lymphocyte ratio and severity of myasthenia gravis in adults: A retrospective study"],"prefix":"10.1016","volume":"106","author":[{"given":"Zhenghao","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aili","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jocn.2022.10.017_b0005","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3390\/cells8070671","article-title":"Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture","volume":"8","author":"Koneczny","year":"2019","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.jocn.2022.10.017_b0010","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ncl.2018.01.002","article-title":"Generalized Myasthenia Gravis: Classification, Clinical Presentation, Natural History, and Epidemiology","volume":"36","author":"Hehir","year":"2018","journal-title":"Neurol Clin"},{"issue":"1","key":"10.1016\/j.jocn.2022.10.017_b0015","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.jocn.2022.10.017_b0020","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3109\/00207454.2014.883391","article-title":"Risk factors of myasthenic crisis after thymectomy in 178 generalized myasthenia gravis patients in a five-year follow-up study","volume":"124","author":"Yu","year":"2014","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.jocn.2022.10.017_b0025","first-page":"1","article-title":"Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in pregnant women with systemic lupus erythematosus","volume":"25","author":"Ekici","year":"2021","journal-title":"J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.jocn.2022.10.017_b0030","first-page":"141","article-title":"Neutrophil-to-Lymphocyte Ratio (NLR) in Canine Inflammatory Bowel Disease (IBD)","volume":"7","author":"Benvenuti","year":"2020","journal-title":"Vet Sci"},{"issue":"1","key":"10.1016\/j.jocn.2022.10.017_b0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12883-019-1245-2","article-title":"The neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are independently associated with neurological disability and brain atrophy in multiple sclerosis","volume":"19","author":"Hemond","year":"2019","journal-title":"BMC Neurol"},{"issue":"10","key":"10.1016\/j.jocn.2022.10.017_b0040","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s10072-017-3068-5","article-title":"Neutrophil to lymphocyte ratio may be a helpful marker to evaluate disease activity in NMOSD","volume":"38","author":"Lin","year":"2017","journal-title":"Neurol Sci"},{"issue":"9","key":"10.1016\/j.jocn.2022.10.017_b0045","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1080\/00207454.2020.1759592","article-title":"The correlation of neutrophil-to-lymphocyte ratio with the presence and short-time curative effect of myashtenia gravis in children: a retrospective study","volume":"131","author":"Jiang","year":"2021","journal-title":"Int J Neurosci"},{"issue":"44","key":"10.1016\/j.jocn.2022.10.017_b0050","doi-asserted-by":"crossref","first-page":"76099","DOI":"10.18632\/oncotarget.18546","article-title":"The correlation of neurtrophil-to-lymphocyte ratio with the presence and activity of myasthenia gravis","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotraget"},{"issue":"23","key":"10.1016\/j.jocn.2022.10.017_b0055","doi-asserted-by":"crossref","first-page":"12964","DOI":"10.3390\/ijms222312964","article-title":"A Review on the Role of Non-Coding RNAs in the Pathogenesis of Myasthenia Gravis","volume":"22","author":"Ghafouri-Fard","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jocn.2022.10.017_b0060","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.3389\/fimmu.2017.01785","article-title":"Immunopathogenesis in myasthenia gravis and neuromyelitis optica","volume":"8","author":"Wang","year":"2017","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jocn.2022.10.017_b0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/nyas.13534","article-title":"Toll-like receptors 7 and 9 in myasthenia gravis thymus: amplifiers of autoimmunity?","volume":"1413","author":"Cavalcante","year":"2018","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.jocn.2022.10.017_b0070","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/cei.13546","article-title":"Roles of cytokines and T cells in the pathogenesis of myasthenia","volume":"203","author":"Uzawa","year":"2021","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"10.1016\/j.jocn.2022.10.017_b0075","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.4049\/jimmunol.1500725","article-title":"Augmentation of Circulating Follicular Helper T Cells and Their Impact on Autoreactive B Cells in Myasthenia Gravis","volume":"197","author":"Zhang","year":"2016","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jocn.2022.10.017_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/25785826.2020.1776079","article-title":"T follicular helper cell subsets: a potential key player in autoimmunity","volume":"44","author":"Kurata","year":"2021","journal-title":"Immunol Med"},{"issue":"1","key":"10.1016\/j.jocn.2022.10.017_b0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/nyas.13522","article-title":"Myasthenia gravis: the role of complement at the neuromuscular junction","volume":"1412","author":"Howard","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jocn.2022.10.017_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00809","article-title":"CD4+T cells of myasthenia gravis patients are characterized by increased IL-21, IL-4 and IL-17A productions and higher presence of PD-1 and ICOS","volume":"11","author":"\u00c7ebi","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jocn.2022.10.017_b0095","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.4049\/jimmunol.1501339","article-title":"Autoreactive T cells from patients with myasthenia gravis are characterized by elevated IL-17, IFN-\u03b3 and GM-CSF and diminished IL-10 production","volume":"196","author":"Cao","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.jocn.2022.10.017_b0100","doi-asserted-by":"crossref","unstructured":"Hou MM, Li YF, He LL, Li XQ, Zhang Y, Zhang SX., et al. Proportions of Th17 cells and Th17-related cytokines in neuromyelitis optica spectrum disorders patients: A meta-analysis. Int Immunopharmacol. 2019; 75: 105793.","DOI":"10.1016\/j.intimp.2019.105793"},{"key":"10.1016\/j.jocn.2022.10.017_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.05.001","article-title":"Myashenia gravis: paradox versus paradigm in autoimmunity","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jocn.2022.10.017_b0110","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2147\/NDT.S311942","article-title":"Neutrophil-to-lymphocyte ratio on admission is an independent risk factor for the severity of neurological impairment at disease onset in patients with a first episode of neuromyelitis optica spectrum disorder","volume":"17","author":"Zhou","year":"2021","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"12","key":"10.1016\/j.jocn.2022.10.017_b0115","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.3390\/ijms21124558","article-title":"Neutrophils: Underestimated Players in the Pathogenesis of Multiple Sclerosis (MS)","volume":"21","author":"De Bondt","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jocn.2022.10.017_b0120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-pathol-052920-040318","article-title":"The Immune Response in Multiple Sclerosis","author":"Rodr\u00edguez","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jocn.2022.10.017_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105793","article-title":"Proportions of Th17 cells and Th17-related cytokines in neuromyelitis optica spectrum disorders patients: A meta-analysis","volume":"75","author":"Hou","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jocn.2022.10.017_b0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jocn.2022.05.002","article-title":"Comparison of neutrophil-to-lymphocyte ratio between myelin oligodendrocyte glycoprotein antibody-associated disease and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders in adults","volume":"101","author":"Duan","year":"2022","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2022.10.017_b0135","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.msard.2017.10.009","article-title":"The neutrophil-to-lymphocyte ratio as disease actvity marker in multiple sclerosis and optic neuritis","volume":"18","author":"Bisgaard","year":"2017","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jocn.2022.10.017_b0140","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12883-021-02432-0","article-title":"Association of neutrophil-to-lymphocyte ratio (NLR) with the prognosis of first attack neuromyelitis optica spectrum diorder (NMOSD): a retrospective cohort study","volume":"21","author":"Xie","year":"2021","journal-title":"BMC Neurol"},{"issue":"2","key":"10.1016\/j.jocn.2022.10.017_b0145","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00415-020-10322-7","article-title":"Neutrophil-to-lymphocyte ratio: a marker of neuroinflammation in multiple sclerosis?","volume":"268","author":"Gelibter","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2022.10.017_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.628024","article-title":"An abnormally high neutrophil-to-lymphocyte ratio is not an independent outcome predictor in AQP4-IgG-Positive NMOSD","volume":"12","author":"Carnero Contentti","year":"2021","journal-title":"Front Immunol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586822004271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586822004271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:32:24Z","timestamp":1760823144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586822004271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":30,"alternative-id":["S0967586822004271"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2022.10.017","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between neutrophil-to-lymphocyte ratio and severity of myasthenia gravis in adults: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2022.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}